CHICAGO (Reuters) - Some 21 percent of patients with advanced brain cancer treated with a modified polio vaccine were alive after three years, compared with 4 percent of patients with similar tumors who received standard therapies, U.S. researchers s...
Original Article: Modified polio vaccine extends lives in U.S. brain cancer study